Technology

Asthma technology innovation fund launched worth over £3m

Asthma UK and the British Lung Foundation, with National Institute for Health Research (NIHR) and the Engineering and Physical Sciences Research Council (EPSRC) are launching a new Asthma Technology Fund that aims to support innovative, life changing technology for people with asthma. Asthma affects 5.4 million people in the UK and results in around 70,000 hospital admissions and 1100 deaths every year. It is a common condition that has the potential to be transformed by technology; Asthma UK’s 2016 Connected Asthma report highlighted the possible benefits of smart inhalers, health apps and remote monitoring to reduce asthma attacks and reduce symptoms. However, four years on, technology options for people with asthma to help them manage their condition are still very limited. To help solv...

FDA approves AI prostate solution

Quantib, an AI solutions provider for radiology, has received FDA clearance for its prostate solution. The solution is a zero-footprint software providing a comprehensive and intuitive workflow for enhanced assessments and is paired with fast processing and image registration enabling real-time workflows.  The release of Quantib’s prostate solution comes after PROMISS and Precision trials indicated the added value of incorporating MRIs in the prostate cancer workflow. Subsequently, guideline changes from the ACR (American College of Radiology) advising that MRIs become standard prior to biopsies adds further to the importance of prostate diagnosis within radiology. Yet with the high level of expertise required for prostate diagnoses, there aren’t enough radiologists to meet growi...

Survey suggests SMEs believe barriers hinder efforts to commercialise IP

Research by R&D IP specialists GovGrant suggests that 83% of UK SMEs believe it’s vital to commercialise IP, but there are too many barriers hindering these efforts. From the responses of SME decision-makers across seven different sectors, the findings show 26% believe the lack of opportunity to patent and scope to innovate is to blame, while 21% claim it’s insufficiency of expertise. The data goes on to show 18% account cost as the biggest obstacle when it comes to business’ IP efforts.  The study also found that just 15% of SMEs think the Government is creating an economic environment that encourages innovation, meaning it is only natural that the lack of opportunity to patent and scope to innovate are perceived as the biggest barriers to business’ IP efforts. However, not ...

Vision-based fall detection software classed as medical device

Kepler Vision Technologies – a developer of vision-based human activity recognition software – has seen its Kepler Night Nurse (KNN) software has officially been registered as a medical device. Its intended use is the “monitoring the mobility of patients with a reduced ability to keep balanced.” Through the use of machine learning and computer vision, KNN is able to detect falls and beyond. Elderly patients are prevented from falling thanks to KNN, which detects when a fall is going to happen and alerts nearby carers. This new technology, based on artificial intelligence, reports its false alarm rate based on the number of false alarms recorded per year. The registration signifies that the software has been tested both internally and in the field to meet the highest specifications and that...

New daytime sleep training device launched

Urgotech has commercially launched its sleep device, Urgonight. Leveraging neurofeedback therapy, it is a daytime sleep training system that trains the brain to produce the brainwaves clinically associated with sleep.  Comprised of a wearable electroencephalogram (EEG) headband and app, it aims to help people naturally learn to increase the brainwaves that impact sleep, using technology that has been clinically proven to help people to fall asleep 40% faster and cut night-time interruptions by half. Neurofeedback technology uses real-time displays of brain activity, audio and visual cues and reward strategies to teach people to identify and modify behaviour to influence a desired outcome. The technology is used to treat and manage conditions such as sleep, ADHD, improve critical think...

Natural Cycles expands into wearable contraception

Natural Cycles, an FDA cleared birth control app in the United States and CE marked birth control app in Europe, has submitted a 510(k) Premarket Notification to the U.S. Food and Drug Administration (FDA). The purpose of the notification is to revise the labelling to expand the types of third-party thermometers, which include wearables already on the market, that can be used with its app. The Natural Cycles app, which received FDA clearance to be marketed as digital contraception in August of 2018, is powered by an algorithm that is able to identify a woman’s daily fertility status based on her basal body temperature and other menstrual data. Currently, users use a standard basal thermometer to take their daily temperature and input that temperature manually into the app. New software has...

Greenlight Guru launches Quality Event Automation service

Greenlight Guru, a medical device quality management software (MDQMS) platform, has launched Quality Event Automation, providing quality teams the ability to automate their quality event processes through custom workflow templates and automated tasks to create efficiency and improve post-market quality management. Medical device quality managers handle quality events by following defined processes and using various forms, flow diagrams and other documents. This manual process can increase the likelihood of missing important steps in the quality event process and force quality teams to manually rework each new quality event initiated. Greenlight Guru’s Quality Event Automation eliminates the inefficiency associated with quality event processes by automating the necessary steps for a quality...

Drug-coated coronary stent system receives CE mark

Biosensors has received the CE Mark for BioFreedomUltra, its new drug-coated coronary stent system. BioFreedom Ultra is Biosensors’ new, thin strut (84µm) CoCr polymer and carrier-free Drug Coated Stent with Biosensors’ Biolimus A9 drug. BA9 is Biosensors’ proprietary highly lipophilic anti-restenotic drug, developed specifically for use in coronary vascular applications.   The BioFreedom Ultra stent will optimise the PCI procedure for High Bleeding Risk (HBR) patients by simplifying stent choice pre-procedure based on the Leaders Free legacy, enhancing procedure success thanks to the stent design and maximising outcomes for HBR patients treated with one-month DAPT.   The Leaders Free III trial enrolled 400 HBR patients at 18 sites, using the sa...

‘Exporting Excellence’ event aims to help business expansion

Crowd has partnered with the Department for International Trade and London & Partners to help create ‘Exporting Excellence,’ aimed to help UK businesses realise their commercial ambitions abroad. This initiative will be held between 21st and 23rd October 2020. Business that are not quite sure if they want to export, or don’t know what markets are suitable for their services, will still get a plan of action to be implemented at a later date. As well as a number of key speakers who will showcase export opportunities, afternoon sessions will enable attendees to book one-on-one meetings with industry experts and export enablers. The event’s speakers come from industries including, AI & tech and healthcare. Global CEO, Jamie Sergeant, said: “Once the business expanded to different marke...

BD receives CE mark for COVID-19 immune function test

BD (Becton, Dickinson and Company) has received the CE mark for a product that assesses immune function in COVID-19 patients. The BD Multitest 6-Color TBNK Reagent with BD Trucount Tubes has been CE marked with expanded clinical application for the identification and enumeration of T-cell subtypes in COVID-19 patients. Data from the first global wave of COVID-19 have shown that patients typically exhibit a remarkable decrease of CD4 and/or CD8 lymphocyte counts with increasing disease severity. Accurate counts of T-cell subsets may be critical in informing the clinical course of action because T-cells are essential for viral killing and antibody response. The BD Multitest-Color TBNK Reagent with BD Trucount Tubes leverages time-tested technology for immune assessment and enables clinicians...

Smart phone diagnostics firm secures £4.5m in funding round

‘TestCard’, which allows people to diagnose common conditions and diseases using the camera on their mobile phone, has secured £4.5 million in its latest funding round.  Secured via corporate finance and venture capital firm ‘West Hill’, TestCard will use the new wave of funding for new product development, advancing regulatory applications, international expansion and further product launches. It will also help bridge the business through to its Series ‘A’ round, currently anticipated for the second quarter of 2021. With the aim of giving people control over their health and taking further strain off the NHS, Testcard’s at-home UTI testing kit, which launches in November, turns a smartphone camera into a clinical grade scanner, providing results which can then be shared with a ...

Device manufacturer launches new anaesthesia machines

Mindray has announced it will be launching its new A8 and A9 anaesthesia machines in the UK market. The two systems are the medical device manufacturer’s most advanced anaesthesia products to date, offering connectivity options and patient safety features.  Both the A8 and A9 are the first devices in the industry to have integrated high flow nasal cannula (HFNC) technology within the anaesthesia machine. The feature helps extend the window of therapeutic action for anaesthetists by prolonging safe oxygenation levels, allowing up to 30 minutes of safe oxygenated apnoea time. Studies by the British Journal of Anaesthesia found that HFNC can more than double the average duration of apnoea before desaturation. Data from a wide range of external monitoring modules such as bispectral i...